Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
15
×
national blog main
boston top stories
life sciences
biotech
boston
clinical trials
national top stories
fda
san francisco blog main
deals
startups
investing
new york blog main
digital health
medical device
medicare
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
software
vc
venture capital
healthcare
indiana blog main
ipo
new york top stories
raleigh-durham top stories
san diego top stories
seattle top stories
boulder/denver blog main
boulder/denver top stories
cancer
crispr
detroit blog main
detroit top stories
drug delivery
eventide asset management
gene editing
What
million
15
×
ipo
new
therapeutics
company
raised
drug
medicines
startup
clinical
developing
digital
raises
tests
advance
based
bio
biosciences
biotech
bio’s
brings
cancer
closed
crispr
genetic
health
healthcare
medical
patients
pipeline
public
sciences
tiny
treat
acquisition
add
adding
adds
aiming
allergan
Language
unset
Current search:
million
×
" boston blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
Teladoc Buys Advance Medical for $352M to Expand Telehealth Services
@xconomy.com
6 years ago
Iora Health Goes Big With $100M to Advance Collaborative Care Model